title: Androgen associated hepatocellular carcinoma with an aggressive course.
abstract: The hepatocellular carcinomas that develop in patients treated with androgens have previously been associated with a benign clinical outcome. We describe a man who developed a hepatocellular carcinoma after 24 years of androgen treatment, whose tumour initially showed partial regression after withdrawal of androgens but subsequently pursued an aggressive and fatal course.
authors.affiliation: Department of Gastroenterology, Royal Infirmary, Manchester.
authors.forename: D
authors.initials: D
authors.lastname: Gleeson
authors.forename: M J
authors.initials: MJ
authors.lastname: Newbould
authors.forename: P
authors.initials: P
authors.lastname: Taylor
authors.forename: R F
authors.initials: RF
authors.lastname: McMahon
authors.forename: B C
authors.initials: BC
authors.lastname: Leahy
authors.forename: T W
authors.initials: TW
authors.lastname: Warnes
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008134:Long-Term Care; D008297:Male; D008777:Methyltestosterone / Q000009:adverse effects*; D008875:Middle Aged
chemical_list: D008777:Methyltestosterone